Autophagy and neuroprotection in astrocytes exposed to 6-hydroxydopamine is negatively regulated by NQO2: relevance to Parkinson’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Autophagy and neuroprotection in astrocytes exposed to 6-hydroxydopamine is negatively regulated by NQO2: relevance to Parkinson’s disease ; volume:13 ; number:1 ; day:7 ; month:12 ; year:2023 ; pages:1-16 ; date:12.2023
Scientific reports ; 13, Heft 1 (7.12.2023), 1-16, 12.2023
- Urheber
-
Janda, Elzbieta
Parafati, Maddalena
Martino, Concetta
Crupi, Francesco
George William, Jonahunnatha Nesson
Reybier, Karine
Arbitrio, Mariamena
Mollace, Vincenzo
Boutin, Jean A.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-44666-7
- URN
-
urn:nbn:de:101:1-2024022308082446207293
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:46 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Janda, Elzbieta
- Parafati, Maddalena
- Martino, Concetta
- Crupi, Francesco
- George William, Jonahunnatha Nesson
- Reybier, Karine
- Arbitrio, Mariamena
- Mollace, Vincenzo
- Boutin, Jean A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neuroprotection in Parkinson’s disease: facts and hopes
Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson’s disease brain
Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokers
Açai Berry Mitigates Parkinson’s Disease Progression Showing Dopaminergic Neuroprotection via Nrf2-HO1 Pathways
Molecular pathways to Parkinson’s disease
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease
Neuroprotection and neurorestoration in the MPTP model for Parkinson's disease
Parkinson’s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes
Astrocytes contribute to toll-like receptor 2-mediated neurodegeneration and alpha-synuclein pathology in a human midbrain Parkinson’s model
Novel gene (TMEM230) linked to Parkinson’s disease
From anticipation to impulsivity in Parkinson’s disease
Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease: removing axonal debris
Neuroprotection in Parkinson’s disease: facts and hopes
Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson’s disease brain
Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokers
Açai Berry Mitigates Parkinson’s Disease Progression Showing Dopaminergic Neuroprotection via Nrf2-HO1 Pathways
Molecular pathways to Parkinson’s disease
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease
Neuroprotection and neurorestoration in the MPTP model for Parkinson's disease
Parkinson’s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes
Astrocytes contribute to toll-like receptor 2-mediated neurodegeneration and alpha-synuclein pathology in a human midbrain Parkinson’s model
Novel gene (TMEM230) linked to Parkinson’s disease
From anticipation to impulsivity in Parkinson’s disease
Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease: removing axonal debris
Neuroprotection in Parkinson’s disease: facts and hopes
Astrocytes have the capacity to act as antigen-presenting cells in the Parkinson’s disease brain
Neuroprotection of low dose carbon monoxide in Parkinson’s disease models commensurate with the reduced risk of Parkinson’s among smokers
Açai Berry Mitigates Parkinson’s Disease Progression Showing Dopaminergic Neuroprotection via Nrf2-HO1 Pathways
Molecular pathways to Parkinson’s disease
Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson’s disease
Neuroprotection and neurorestoration in the MPTP model for Parkinson's disease
Parkinson’s disease-associated LRRK2-G2019S mutant acts through regulation of SERCA activity to control ER stress in astrocytes
Astrocytes contribute to toll-like receptor 2-mediated neurodegeneration and alpha-synuclein pathology in a human midbrain Parkinson’s model
Novel gene (TMEM230) linked to Parkinson’s disease
From anticipation to impulsivity in Parkinson’s disease